WHO ICTRP trial
Typhlitis study.
NL-OMON21843 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON21843 |
|---|---|
| Public title | Typhlitis study. |
| Scientific title | Identification of predictive parameters for typhlitis in AML patients treated with intensive chemotherapy. |
| Primary sponsor | Prof.dr. E. Vellenga Dept. of Hematology University Medical Center Groningen P.O. Box 30.001 9700 RB Groningen The Netherlands Phone: +31 50 361 61 61 E-mail: e.vellenga2int.umcg.nl |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Acute myeloid leukemia Acute myeloide leukemie |
| Interventions | 1. Blood and stool samples will be collected; 2. CT-scan of abdomen at day 10-12; 3. Mucositis score will be determined; 4. DNA isolation from normal peripheral blood. |
| Registration date | May 6, 2009 |
| Target size | 45 |
| Secondary IDs | NL692;NTR1800;MEC UMCG : 2008/113;ISRCTN wordt niet meer aangevraagd |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: